BSGM:NSD-Biosig Technologies Inc (USD)

COMMON STOCK | Medical Devices | NSD

Last Closing Price

USD 0.62

Change

+0.02 (+3.02)%

Market Cap

USD 0.03B

Volume

0.07M

Avg Analyst Target

N/A

Avg User Target

USD
Average Analyst Rating

N/A

Fundamental Analysis

Verdict

BSGM Stock Forecast & Price:
Based on the Biosig Technologies Inc stock forecasts from 0 analysts, the average analyst target price for Biosig Technologies Inc is not available over the next 12 months. Biosig Technologies Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Biosig Technologies Inc is Bearish, which is based on 1 positive signals and 5 negative signals. At the last closing, Biosig Technologies Inc’s stock price was USD 0.62. Biosig Technologies Inc’s stock price has changed by +2.79% over the past week, -12.83% over the past month and -81.38% over the last year.

No recent analyst target price found for Biosig Technologies Inc
No recent average analyst rating found for Biosig Technologies Inc

About Biosig Technologies Inc (BSGM:NSD)

BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hard ...Read More

Company Website : https://www.biosig.com

Address : 55 Greens Farms Road, Westport, CT, United States, 06880

Employees : 50

Fiscal Year End : December

Currency: USD

Country : USA

Technical Indicators

Beta : 1.64

52 Week High : 4.10

Short Ratio : 5.31

52 Week Low : 0.50

Shorted Shares : 1,847,694

200 Day Moving Average : 1.59

Shorted Shares Previous Month : 1,880,448

50 Day Moving Average : 0.75

Shares Held By Insiders : 10.77%

Short Percentage : 4.68%

Shares Held by Institutions : 11.38%

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2022-08-09 )

Largest Industry Peers for Medical Devices

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
DXCM DexCom Inc

-6.28 (-6.87%)

 USD35.88B 217.62 88.85
ALGN Align Technology Inc

-19.42 (-6.63%)

 USD23.09B 37.57 25.05
PODD Insulet Corporation

-4.38 (-1.67%)

 USD18.26B 392.63 129.78
LVGO Livongo Health, Inc

N/A

 USD14.20B N/A N/A
ABMD ABIOMED Inc

-12.06 (-4.11%)

 USD13.23B 97.62 49.02
BRKR Bruker Corporation

-1.82 (-2.93%)

 USD9.33B 34.71 19.62
SWAV Shockwave Medical Inc

+37.84 (+17.06%)

 USD7.99B 272.12 210.58
IART Integra LifeSciences Holdings

-0.63 (-1.13%)

 USD4.65B 28.01 16.36
IRTC iRhythm Technologies Inc

-7.97 (-5.33%)

 USD4.43B N/A -39.60
WMGI Wright Medical Group N.V

N/A

 USD3.90B N/A 50.67

ETFs Containing BSGM

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Medical Devices)		 Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -72.27% 7% F 11% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -72.27% 7% F 11% F
Trailing 12 Months  
Capital Gain -80.25% 11% F 12% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -80.25% 11% F 12% F
Trailing 5 Years  
Capital Gain -57.06% 33% F 17% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -57.06% 33% F 16% F
Average Annual (5 Year Horizon)  
Capital Gain 47.88% 79% C+ 89% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 47.88% 79% C+ 89% B+
Risk Return Profile  
Volatility (Standard Deviation) 128.08% 19% F 9% F
Risk Adjusted Return 37.38% 68% D+ 70% C-
Market Capitalization 0.03B 17% F 10% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Medical Devices)		 Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio N/A N/A N/A N/A N/A
Price/Book Ratio 2.82 47% F 33% F
Price / Cash Flow Ratio -967.17 99% A+ 98% A+
EV/EBITDA -0.56 44% F 62% D-
Management Effectiveness  
Return on Equity -215.19% 8% F 6% F
Return on Invested Capital -272.88% 2% F 5% F
Return on Assets -111.03% 2% F 1% F
Debt to Equity Ratio N/A N/A N/A N/A N/A
Technical Ratios  
Dividend Yield N/A N/A N/A N/A N/A
Short Ratio 5.31 33% F 27% F
Short Percent 4.68% 38% F 35% F
Beta 1.64 23% F 19% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date
New Post

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.